# Characterization and anti-inflammatory studies of supramolecular assemblies of chlorogenic acids with metal ions

**Authors:** Zhen-Min Zhang, Ru-Yue Zhang, Lian Zhu, Zi-Xuan Liu, Han-Xiu Deng, Jie-Fu Tang, Jia-Yu Zhang, Wei Cai

PMC · DOI: 10.3389/fphar.2025.1726226 · Frontiers in Pharmacology · 2026-02-09

## TL;DR

This study shows that combining chlorogenic acids with iron and copper enhances their anti-inflammatory effects by inhibiting key inflammatory pathways.

## Contribution

The novel contribution is demonstrating that chlorogenic acid-metal supramolecules have enhanced anti-inflammatory activity via NF-κB pathway inhibition.

## Key findings

- Chlorogenic acid-metal complexes showed significantly enhanced anti-inflammatory effects compared to pure chlorogenic acids.
- The complexes inhibited the production of inflammatory mediators like NO, IL-6, IL-1β, and TNF-α.
- The anti-inflammatory mechanism involves inhibition of the NF-κB signaling pathway and downregulation of iNOS and COX-2.

## Abstract

Self-assembled natural small molecules are believed to have numerous potential applications, particularly in the material and pharmaceutical industries, as self-assembly increases the anti-inflammatory, antitumor, antiviral, and other biological activities. In this study, we synthesized more potent potential anti-inflammatory agents by combining chlorogenic acids with metals (iron and copper).

Supramolecular assemblies were synthesized by combining chlorogenic acids with iron and copper. The synthesis conditions were optimized using mass spectrometry. The resulting complexes were comprehensively characterized by ultraviolet-visible spectroscopy, Fourier-transform infrared spectroscopy, and mass spectrometry to confirm their formation and stoichiometry. The anti-inflammatory activity was evaluated in vitro using lipopolysaccharide-induced RAW264.7 macrophages. The production of inflammatory mediators (NO, IL-6, IL-1β, TNF-α) was measured. Mechanistic studies were conducted to assess the effects on the NF-κB signaling pathway and the expression of downstream proteins iNOS and COX-2.

Characterization data confirmed the successful formation of chlorogenic acid-metal supramolecules, primarily in a 1:1 stoichiometry. These metal-based complexes exhibited significantly enhanced anti-inflammatory effects compared to the parent chlorogenic acid molecules. In vitro assays demonstrated their potent suppression of key inflammatory mediators, including NO, IL-6, IL-1β, and TNF-α. Mechanistic investigations revealed that the enhanced activity was achieved through the effective inhibition of the NF-κB signaling pathway, leading to the downregulated expression of iNOS and COX-2 proteins.

The findings confirm that complexation with metals (iron and copper) successfully enhances the anti-inflammatory efficacy of chlorogenic acids. The primary mechanism involves the inhibition of the NF-κB pathway. This study provides a novel and efficient strategy for augmenting the bioactivities of natural products and highlights the considerable potential of chlorogenic acid-metal supramolecular assemblies as a promising new class of anti-inflammatory agents.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2), COX2 (cytochrome c oxidase subunit II), NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** iron (PubChem CID 23925), copper (PubChem CID 23978), NO (PubChem CID 24822), IL-6 (PubChem CID 165368475)

## Full-text entities

- **Genes:** COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, ISYNA1 (inositol-3-phosphate synthase 1) [NCBI Gene 51477] {aka INO1, INOS, IPS, IPS 1, IPS-1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** cardiovascular disease (MESH:D002318), Cytotoxicity (MESH:D064420), ulcerative colitis (MESH:D003093), Infusion (MESH:D000075662), Inflammation (MESH:D007249), inflammatory drugs (MESH:D000081015), viral infections (MESH:D014777)
- **Chemicals:** nitrogen (MESH:D009584), SDS (MESH:D012967), polyvinylidene fluoride (MESH:C024865), Cu (MESH:D003300), phenylmethylsulfonyl fluoride (MESH:D010664), Tween 20 (MESH:D011136), potassium bromide (MESH:C039004), Alexa Fluor 488 (MESH:C000711379), C (MESH:D002244), Triton X-100 (MESH:D017830), ACN (MESH:C032159), L-NAME (MESH:D019331), CGA (MESH:D002726), NO (MESH:D009614), NA (MESH:C473200), saline (MESH:D012965), CO2 (MESH:D002245), methanol (MESH:D000432), benzene (MESH:D001554), polyphenol (MESH:D059808), water (MESH:D014867), metal (MESH:D008670), Cu2+ (-), olefin (MESH:D000475), O (MESH:D010100), Fe (MESH:D007501), phenolic acids (MESH:C017616), paraformaldehyde (MESH:C003043), ICAA (MESH:C100434), LPS (MESH:D008070), formic acid (MESH:C030544)
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926475/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926475/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926475/full.md

---
Source: https://tomesphere.com/paper/PMC12926475